Queensland Health confirms rare strain of monkeypox detected in Metro South region
Queensland Health confirmed the case of monkeypox (Mpox) was detected in the state's Metro South region.
Testing revealed it to be the Clade 1 strain of the virus - marking the second time in history the more serious strain has ever been detected in Australia.
A Clade 1 strain of the monkeypox virus was detected in a returned Australian traveller, Queensland Health has confirmed. Picture: Supplied
The case was acquired overseas but authorities say the risk to the wider community is very low.
Queensland Health confirmed exposure to the public had been limited and contact tracing was underway after the detection.
According to the Australian Immunisation Handbook, the symptoms of Mpox can include fever, swollen lymph nodes, fatigue, headache
and muscle aches, followed by a rash within 2-4 days of infection.
It spreads primarily through close or intimate contact.
Complications of the virus can range from bacterial infections to enciphalitus and pneumonia.
The Clade 1 strain of the virus is known cause higher numbers of severe illnesses.
Queensland Health said public exposure has been limited. Picture: NewsWire/Glenn Campbell
Free Mpox vaccines are available to high-risk groups through sexual health clinics and GPs.
'Vaccination is available for post-exposure prophylaxis as well as primary preventive vaccination. High risk groups, including all sexually active gay, bisexual or other men who have sex with men and their partners, are eligible for free vaccines through sexual health clinics and general practitioners,' Minister for Health and Ambulance Services Tim Nicholls said.
Minister for Health Tim Nicholls said Queensland health was monitoring the situation. Picture: NewsWire/Tertius Pickard
Two doses are recommended for optimal protection.
Those travelling to areas with Clade 1 transmission are encouraged to get vaccinated before departure.
Queensland Health is monitoring the situation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Australian
12 hours ago
- The Australian
Spike in adverse event reports for ADHD medication Vyvanse
Authorities are investigating a spike in incidents involving one of Australia's most widely used ADHD medications. Adverse event reports linked to medication Vyvanse have spiked massively this year, and the manufacturer says no changes in the chemical production have been made. 'The Therapeutic Goods Administration (TGA) is currently investigating a potential safety signal associated with Vyvanse, including independent testing of the medicine through the TGA Laboratories,' a spokesperson told NewsWire. 'The investigation is the result of a recent increase in adverse event notifications relating to concerns about the quality, safety, and reduced effectiveness of the drug.' The TGA issued an alert about a typo on the Vyvanse label earlier this year. Picture: TGA 'There are no compliance signals currently under investigation for the facilities used in the manufacture of this product.' A 'signal' is detection of a pattern which requires further investigation. While not formally a pattern in the TGA's eyes, reports of adverse events such as anxiety, ineffectiveness and insomnia have increased massively this year. There have also been 88 reports of issues with the medicines label, which was flagged by the TGA earlier this year for minor typos; however, one of the typos added an extra 'S' to the word capsule; 'Each capsules contains 60mg lisdexamfetamine dimesilate'. The TGA maintains the Database of Adverse Event Notifications, where people report issues with medications. There have been 320 adverse events linked to Vyvanse in the first half of this year, compared to nine reports in the second half of 2024. Inclusion in the database does not confirm the incident is caused by the medication. Reports of ineffective Vyvanse have hit 150 so far this year, along with 88 reports of anxiety, and 73 reports that the therapeutic response has decreased. Last year, 1.8m Vyvanse prescriptions were written in Australia, excluding Department of Veterans' Affairs patients, over-the-counter drugs, private prescriptions and public inpatient prescriptions. Picture: NewsWire / Martin Ollman Prescriptions of Vyvanse have been steadily increasing for the past few years. More than 958,000 scripts were written by public system health workers in 2022, rising to 1.4 million in 2023, and then 1.8m last year, government data shows. In a statement, supplier Takeda Pharmaceuticals Australia said a change of manufacturing facility in 2024 did not alter the chemical composition of the medicine. 'There have been no changes to the formulation,' a Takeda spokesperson told the ABC. Vyvanse was produced with strict quality controls, in line with Australia's Therapeutics Goods Act, the spokesperson said. The labelling typo did not affect the quality of the medication, they said. Blair Jackson Reporter Blair's journalism career has taken him from Perth, to New Zealand, Queensland and now Melbourne. Blair Jackson
News.com.au
15 hours ago
- News.com.au
Spike in ADHD medication adverse event reports
Authorities are investigating a spike in incidents involving one of Australia's most widely used ADHD medications. Adverse event reports linked to medication Vyvanse have spiked massively this year, and the manufacturer says no changes in the chemical production have been made. 'The Therapeutic Goods Administration (TGA) is currently investigating a potential safety signal associated with Vyvanse, including independent testing of the medicine through the TGA Laboratories,' a spokesperson told NewsWire. 'The investigation is the result of a recent increase in adverse event notifications relating to concerns about the quality, safety, and reduced effectiveness of the drug.' 'There are no compliance signals currently under investigation for the facilities used in the manufacture of this product.' A 'signal' is detection of a pattern which requires further investigation. While not formally a pattern in the TGA's eyes, reports of adverse events such as anxiety, ineffectiveness and insomnia have increased massively this year. There have also been 88 reports of issues with the medicines label, which was flagged by the TGA earlier this year for minor typos; however, one of the typos added an extra 'S' to the word capsule; 'Each capsules contains 60mg lisdexamfetamine dimesilate'. The TGA maintains the Database of Adverse Event Notifications, where people report issues with medications. There have been 320 adverse events linked to Vyvanse in the first half of this year, compared to nine reports in the second half of 2024. Inclusion in the database does not confirm the incident is caused by the medication. Reports of ineffective Vyvanse have hit 150 so far this year, along with 88 reports of anxiety, and 73 reports that the therapeutic response has decreased. Prescriptions of Vyvanse have been steadily increasing for the past few years. More than 958,000 scripts were written by public system health workers in 2022, rising to 1.4 million in 2023, and then 1.8m last year, government data shows. In a statement, supplier Takeda Pharmaceuticals Australia said a change of manufacturing facility in 2024 did not alter the chemical composition of the medicine. 'There have been no changes to the formulation,' a Takeda spokesperson told the ABC. Vyvanse was produced with strict quality controls, in line with Australia's Therapeutics Goods Act, the spokesperson said. The labelling typo did not affect the quality of the medication, they said.
News.com.au
17 hours ago
- News.com.au
Measles alert issued across NT airports, tourism hotspots
Northern Territory health authorities have issued a measles alert after a man travelled through multiple tourism hotspots before ending up in hospital in north Queensland. NT Health issued the alert on Saturday morning, warning anyone who was on tourism trips in the state, at restaurant in Kakadu National Park, or travelled through Darwin or Alice Springs Airports on specific dates in July to be alert for measles symptoms. These include a fever, sore eyes, a runny nose, a cough, and a blotchy red rash. 'Check your vaccination status,' an NT Health spokesperson said. 'Measles is highly contagious but preventable with two doses of a measles-containing vaccine.' Health authorities suspect the man who travelled while infectious acquired measles in Indonesia. 'The NT Centre for Disease Control is urging Territorians to be alert following confirmation of a measles case who travelled through Darwin and Alice Springs while infectious,' the alert reads. 'The individual, likely infected overseas, visited multiple public locations in the NT between July 17 and 23.' NT Health says the man was likely infectious when he went on an all-day tour with Ethical Adventures in Litchfield National Park on July 17. The next day, he left for an overnight tour with AAPT Kings Jabiru, and was at the Mercure Kakadu Crocodile Hotel in Jabiru from 6pm to 8pm on July 18. The measles alert does not account for his movements the next two days, but the next listed location is the Museum and Art Gallery of the Northern Territory, from 1pm to 3pm on July 20. It is believed the man then went to Darwin Airport at 3.30pm and flew to Alice Springs on Qantas flight QF1960, arriving at 7pm. On Wednesday, July 23, the man flew from Alice Springs to Cairns on Air North flight TL361. 'Anyone who attended these locations during these times should monitor for symptoms … Symptoms can take up to 18 days after exposure to develop,' the alert said. 'The vaccine is safe and effective, and available from your GP, local health centre, Aboriginal health clinic, and vaccinating pharmacies.'
